Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-275291 in Hormone Refractory Prostate Cancer
NCT00040755Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2002
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rebimastat in prostate cancer (PCa), sponsored by National Cancer Institute. Started May 2002; status: completed.
02
Drugs
rebimastat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00040755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040755.